Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China
· Delayed Price · Currency is CNY 4.470
+0.030 (0.68%)
Apr 29, 2026, 3:00 PM CST
SHA:600572 Revenue
Zhejiang CONBA Pharmaceutical had revenue of 1.91B CNY in the quarter ending March 31, 2026, with 13.10% growth. This brings the company's revenue in the last twelve months to 6.69B, up 4.99% year-over-year. In the year 2025, Zhejiang CONBA Pharmaceutical had annual revenue of 6.47B, down -0.64%.
Revenue (ttm)
6.69B
Revenue Growth
+4.99%
P/S Ratio
1.69
Revenue / Employee
795.88K
Employees
8,411
Market Cap
11.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.47B | -41.73M | -0.64% |
| Dec 31, 2024 | 6.52B | -217.63M | -3.23% |
| Dec 31, 2023 | 6.73B | 732.35M | 12.20% |
| Dec 31, 2022 | 6.00B | -567.74M | -8.64% |
| Dec 31, 2021 | 6.57B | 659.17M | 11.16% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mayinglong Pharmaceutical Group | 3.91B |
| Shanghai Yizhong Pharmaceutical | 317.08M |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Yantai Dongcheng Pharmaceutical Group | 2.68B |
| Porton Pharma Solutions | 3.50B |
| Henan Lingrui Pharmaceutical | 3.96B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Guangdong Taienkang Pharmaceutical | 674.49M |